These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 9508172

  • 1. In vitro cytotoxicity of docetaxel in childhood acute leukemias.
    Consolini R, Pui CH, Behm FG, Raimondi SC, Campana D.
    J Clin Oncol; 1998 Mar; 16(3):907-13. PubMed ID: 9508172
    [Abstract] [Full Text] [Related]

  • 2. Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. II. Potent cytotoxicity of 2-chloro-deoxyadenosine in acute lymphoblastic leukemia.
    Kumagai M, Manabe A, Coustan-Smith E, Blakley RL, Beck WT, Santana VM, Behm FG, Raimondi SC, Campana D.
    Leukemia; 1994 Jul; 8(7):1116-23. PubMed ID: 7913512
    [Abstract] [Full Text] [Related]

  • 3. Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines.
    Avramis IA, Kwock R, Avramis VI.
    Anticancer Res; 2001 Jul; 21(4A):2281-6. PubMed ID: 11724283
    [Abstract] [Full Text] [Related]

  • 4. Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.
    Ito C, Evans WE, McNinch L, Coustan-Smith E, Mahmoud H, Pui CH, Campana D.
    J Clin Oncol; 1996 Aug; 14(8):2370-6. PubMed ID: 8708730
    [Abstract] [Full Text] [Related]

  • 5. Divergent effect of taxol on proliferation, apoptosis and nitric oxide production in MHH225 CD34 positive and U937 CD34 negative human leukaemia cells.
    Al-alami O, Sammons J, Martin JH, Hassan HT.
    Leuk Res; 1998 Oct; 22(10):939-45. PubMed ID: 9766754
    [Abstract] [Full Text] [Related]

  • 6. Stroma-supported immunocytometric assay (SIA): a novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs.
    Campana D, Manabe A, Evans WE.
    Leukemia; 1993 Mar; 7(3):482-8. PubMed ID: 7680404
    [Abstract] [Full Text] [Related]

  • 7. Preclinical evaluation of docetaxel (Taxotere).
    Lavelle F, Bissery MC, Combeau C, Riou JF, Vrignaud P, André S.
    Semin Oncol; 1995 Apr; 22(2 Suppl 4):3-16. PubMed ID: 7740328
    [Abstract] [Full Text] [Related]

  • 8. [Effect of a new anticancer drug, docetaxel (RP56976), on human leukemia cell lines].
    Murata K, Sato T, Kanamaru R.
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):307-13. PubMed ID: 7906506
    [Abstract] [Full Text] [Related]

  • 9. In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells.
    Braakhuis BJ, Hill BT, Dietel M, Kelland LR, Aapro MS, Zoli W, Lelieveld P.
    Anticancer Res; 1994 Feb; 14(1A):205-8. PubMed ID: 7909419
    [Abstract] [Full Text] [Related]

  • 10. Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. I. Cytotoxicity of interferon alpha in acute lymphoblastic leukemia.
    Manabe A, Yi T, Kumagai M, Campana D.
    Leukemia; 1993 Dec; 7(12):1990-5. PubMed ID: 8255098
    [Abstract] [Full Text] [Related]

  • 11. The scientific rationale for developing taxoids.
    Aapro M.
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():33-6. PubMed ID: 8862709
    [Abstract] [Full Text] [Related]

  • 12. Cyclosporin A induces apoptosis in childhood acute lymphoblastic leukemia cells.
    Ito C, Ribeiro RC, Behm FG, Raimondi SC, Pui CH, Campana D.
    Blood; 1998 Feb 01; 91(3):1001-7. PubMed ID: 9446662
    [Abstract] [Full Text] [Related]

  • 13. Cytotoxicity of paclitaxel and docetaxel in human neuroblastoma cell lines.
    Riccardi A, Servidei T, Tornesello A, Puggioni P, Mastrangelo S, Rumi C, Riccardi R.
    Eur J Cancer; 1995 Feb 01; 31A(4):494-9. PubMed ID: 7576952
    [Abstract] [Full Text] [Related]

  • 14. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
    Kelland LR, Abel G.
    Cancer Chemother Pharmacol; 1992 Feb 01; 30(6):444-50. PubMed ID: 1356649
    [Abstract] [Full Text] [Related]

  • 15. Taxoids: effective agents in anthracycline-resistant breast cancer.
    Ravdin PM.
    Semin Oncol; 1995 Dec 01; 22(6 Suppl 13):29-34. PubMed ID: 8604450
    [Abstract] [Full Text] [Related]

  • 16. Comparison of paclitaxel and docetaxel (Taxotere) in gynecologic and breast cancer cell lines with the ATP-cell viability assay.
    Untch M, Untch A, Sevin BU, Angioli R, Perras JP, Koechli O, Averette HE.
    Anticancer Drugs; 1994 Feb 01; 5(1):24-30. PubMed ID: 7910494
    [Abstract] [Full Text] [Related]

  • 17. Docetaxel (Taxotere) for the treatment of anthracycline-resistant breast cancer.
    Ravdin PM.
    Semin Oncol; 1997 Aug 01; 24(4 Suppl 10):S10-18-S10-21. PubMed ID: 9275002
    [Abstract] [Full Text] [Related]

  • 18. Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells.
    Hennequin C, Giocanti N, Favaudon V.
    Cancer Res; 1996 Apr 15; 56(8):1842-50. PubMed ID: 8620502
    [Abstract] [Full Text] [Related]

  • 19. Docetaxel (Taxotere): an effective agent in the management of second-line breast cancer.
    van Oosterom AT.
    Semin Oncol; 1995 Dec 15; 22(6 Suppl 13):22-8. PubMed ID: 8604449
    [Abstract] [Full Text] [Related]

  • 20. Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro.
    Hill BT, Whelan RD, Shellard SA, McClean S, Hosking LK.
    Invest New Drugs; 1994 Dec 15; 12(3):169-82. PubMed ID: 7896535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.